Immersive technology at Merck: Using Microsoft HoloLens to reimagine the molecular R&D process
In Spring 2016, Merck’s Applied Technology Team asked Infusion to review some use-cases that they had identified for Immersive Technology. They were curious about our understanding of the hardware market for these devices. We closed a short, one-person, five-week engagement to review their identified scenarios and suggest what areas of AR/VR/MR were most suitable and what devices would be the best fit. Upon delivering a report that identified HoloLens as the front-runner, due to their scenarios being best realized in mixed reality, Merck engaged us to develop a prototype for one use-case.